Wenpeng Cai
Chinese Academy Of Medical Sciences And Peking Union Medical College
Beijing, 100021, China
Beijing, 100021, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
Plasma proteomic and metabolomic profiling reveals molecular features relevant to neoadjuvant therapy response in locally advanced esophageal squamous cell carcinoma.
Journal: Molecular cancer
Published: January 14, 2026
RAD21 drives tumor progression and confers anti-PD-1 resistance by reprogramming tumor-associated macrophages via upregulation of CSF1 signaling.
Journal: Cancer letters
Published: December 12, 2025
RAD21-mediated epigenetic regulation promotes lung adenocarcinoma progression and sensitizes cancer cells to ERK-targeted therapy.
Journal: Cancer letters
Published: July 29, 2025
SLAMF receptors: key regulators of tumor progression and emerging targets for cancer immunotherapy.
Journal: Molecular cancer
Published: December 10, 2024
The epigenetic hallmarks of immune cells in cancer.
Journal: Molecular cancer
Published: November 17, 2024
Neutrophils in cancer: At the crucial crossroads of anti-tumor and pro-tumor.
Journal: Cancer communications (London, England)
Published: September 19, 2024
Targeting LSD1 in cancer: Molecular elucidation and recent advances.
Journal: Cancer letters
Published: May 09, 2024
The pathogenic germline ETV4 P433L mutation identified in multiple primary lung cancer affect tumor stem-like property by Wnt/β-catenin pathway.
Journal: Cell death & disease
Published: December 04, 2023
Showing 1-9 of 9
Last Updated: 09/26/2026